Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

299
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
299
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

205
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
205
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.2K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

205
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
205
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

272
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
272
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

445
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
445

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuroimmune lipidome dysregulation in major depressive disorder: A meta-analysis of peripheral endocannabinoid and N-acylethanolamine signaling.

Brain, behavior, and immunity·2026
Same author

Evaluating the Causal Relationship between Personality and Parkinson's Disease.

Current neurovascular research·2026
Same author

Comparative anatomy and metabolic profiles of brown and white adipose tissue in humans.

Frontiers in endocrinology·2026
Same author

Molecular and immunological heterogeneity of eosinophilic esophagitis: Insights and subtyping.

PloS one·2026
Same author

Individualized prediction of survival after brain metastasis development in patients with breast cancer.

Journal of neuro-oncology·2026
Same author

Cross-Platform and cross-species lipidomic profiling identifies promising biomarkers for adolescent major depressive disorder.

Molecular psychiatry·2026

Related Experiment Video

Updated: Dec 28, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.0K

Knowledge-Based Compact Disease Models: A Rapid Path from High-Throughput Data to Understanding Causative Mechanisms

Anatoly Mayburd1, Ancha Baranova2,3

  • 1The Center of the Study of Chronic Metabolic and Rare Diseases, School of Systems Biology, College of Science, George Mason University, Fairfax, VA, 22030, USA.

Methods in Molecular Biology (Clifton, N.J.)
|August 30, 2017
PubMed
Summary

This study introduces Compact Disease Models (CDM) to refine gene lists from high-throughput profiling, improving mechanistic hypothesis generation for complex diseases like Alzheimer's. The approach enhances data interpretation and aids in understanding neurodegenerative pathways.

Keywords:
AffymetrixAlzheimer’sAntihypertensive drugsIlluminaKnowledge-based algorithmsNetworkProtein traffic vesiclesSignature

More Related Videos

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.1K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

21.1K

Related Experiment Videos

Last Updated: Dec 28, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.0K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.1K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

21.1K

Area of Science:

  • Genomics
  • Computational Biology
  • Neuroscience

Background:

  • High-throughput profiling generates extensive gene lists, often containing irrelevant data that hinders mechanistic hypothesis generation.
  • Identifying mechanistically relevant targets is crucial for effective experimental design and data interpretation in complex phenotypes.

Purpose of the Study:

  • To develop a method for refining gene lists from high-throughput data to generate mechanistically relevant insights.
  • To apply this method to Alzheimer's disease (AD) to identify potential pathogenic pathways.

Main Methods:

  • Enrichment analysis across datasets to establish evidence consistency tiers for candidate gene lists.
  • Empirical cutoff establishment via ontological and semantic enrichment.
  • Re-expansion of shortened gene lists and network analysis using Ingenuity Pathway Assistant to form Compact Disease Models (CDM).

Main Results:

  • The CDM approach successfully distilled gene lists, highlighting the potential role of protein traffic vesicles in AD pathogenesis.
  • Hypotheses regarding spontaneous protein misfolding and reduced growth stimulation as neurodegeneration shortcuts were proposed.
  • A pleiotropic model for early-stage AD was suggested, involving AT-1 mediated effects, cytoskeleton remodeling, and hormonal signaling.

Conclusions:

  • Compact Disease Model generation offers a flexible, mechanism-centered approach for high-throughput data analysis.
  • This method facilitates the translation of complex data into testable hypotheses for diseases like Alzheimer's.
  • The study underscores the potential significance of protein trafficking and related pathways in early AD development.